Application 018297
- Type
- NDA
- Sponsor
- ABBOTT
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | LOPURIN | ALLOPURINOL | TABLET;ORAL | 100MG | No | No |
| 002 | LOPURIN | ALLOPURINOL | TABLET;ORAL | 300MG | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| N018297-001 | LOPURIN | ALLOPURINOL | 100MG | TABLET / ORAL | Approved before 1982 | ||
| N018297-002 | LOPURIN | ALLOPURINOL | 300MG | TABLET / ORAL | Approved before 1982 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | N018297-001 | LOPURIN | 100MG | TABLET / ORAL | Approved before 1982 | 84e616aacf4f… | ||
| 2026-09-14 22:38:34 | 2026-08 | N018297-002 | LOPURIN | 300MG | TABLET / ORAL | Approved before 1982 | 84e616aacf4f… | ||
| 2026-08-18 06:07:40 | 2026-07 | N018297-001 | LOPURIN | 100MG | TABLET / ORAL | Approved before 1982 | caaa826d4ba7… | ||
| 2026-08-18 06:07:40 | 2026-07 | N018297-002 | LOPURIN | 300MG | TABLET / ORAL | Approved before 1982 | caaa826d4ba7… | ||
| 2026-02-19 14:30 UTC | 2026-02 | N018297-001 | LOPURIN | 100MG | TABLET / ORAL | Approved before 1982 | 011fe1cb6892… | ||
| 2026-02-19 14:30 UTC | 2026-02 | N018297-002 | LOPURIN | 300MG | TABLET / ORAL | Approved before 1982 | 011fe1cb6892… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N018297-001 | LOPURIN | 100MG | TABLET / ORAL | Approved before 1982 | 31067a03dcf5… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N018297-002 | LOPURIN | 300MG | TABLET / ORAL | Approved before 1982 | 31067a03dcf5… | ||
| 2025-08-23 18:47 UTC | 2025-08 | N018297-001 | LOPURIN | 100MG | TABLET / ORAL | Approved before 1982 | 6a471c1ec25d… | ||
| 2025-08-23 18:47 UTC | 2025-08 | N018297-002 | LOPURIN | 300MG | TABLET / ORAL | Approved before 1982 | 6a471c1ec25d… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N018297-001 | LOPURIN | 100MG | TABLET / ORAL | Approved before 1982 | fd3edfee7708… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N018297-002 | LOPURIN | 300MG | TABLET / ORAL | Approved before 1982 | fd3edfee7708… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N018297-001 | LOPURIN | 100MG | TABLET / ORAL | Approved before 1982 | b8a1b40f171c… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N018297-002 | LOPURIN | 300MG | TABLET / ORAL | Approved before 1982 | b8a1b40f171c… | ||
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N018297-001 | LOPURIN | 100MG | TABLET / ORAL | Approved before 1982 | 03ed91905a0d… | ||
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N018297-002 | LOPURIN | 300MG | TABLET / ORAL | Approved before 1982 | 03ed91905a0d… | ||
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N018297-001 | LOPURIN | 100MG | TABLET / ORAL | Approved before 1982 | 2680178bc6a6… | ||
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N018297-002 | LOPURIN | 300MG | TABLET / ORAL | Approved before 1982 | 2680178bc6a6… | ||
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N018297-001 | LOPURIN | 100MG | TABLET / ORAL | Approved before 1982 | 5bbf6a4d5a75… | ||
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N018297-002 | LOPURIN | 300MG | TABLET / ORAL | Approved before 1982 | 5bbf6a4d5a75… | ||
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N018297-001 | LOPURIN | 100MG | TABLET / ORAL | Approved before 1982 | d8e5a09893c0… | ||
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N018297-002 | LOPURIN | 300MG | TABLET / ORAL | Approved before 1982 | d8e5a09893c0… | ||
| 2024-10-29 15:01 UTC | 2024-10 | N018297-001 | LOPURIN | 100MG | TABLET / ORAL | Approved before 1982 | d06236e962d9… | ||
| 2024-10-29 15:01 UTC | 2024-10 | N018297-002 | LOPURIN | 300MG | TABLET / ORAL | Approved before 1982 | d06236e962d9… | ||
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N018297-001 | LOPURIN | 100MG | TABLET / ORAL | Approved before 1982 | 79d66fd596c7… | ||
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N018297-002 | LOPURIN | 300MG | TABLET / ORAL | Approved before 1982 | 79d66fd596c7… | ||
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | N018297-001 | LOPURIN | 100MG | TABLET / ORAL | Approved before 1982 | 301d65b070ca… | ||
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | N018297-002 | LOPURIN | 300MG | TABLET / ORAL | Approved before 1982 | 301d65b070ca… | ||
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | N018297-001 | LOPURIN | 100MG | TABLET / ORAL | Approved before 1982 | 1e350fbaab3a… | ||
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | N018297-002 | LOPURIN | 300MG | TABLET / ORAL | Approved before 1982 | 1e350fbaab3a… | ||
| 2024-05-31 18:47 UTC | 2024-05 | N018297-001 | LOPURIN | 100MG | TABLET / ORAL | Approved before 1982 | 8072bd15b7f6… | ||
| 2024-05-31 18:47 UTC | 2024-05 | N018297-002 | LOPURIN | 300MG | TABLET / ORAL | Approved before 1982 | 8072bd15b7f6… | ||
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | N018297-001 | LOPURIN | 100MG | TABLET / ORAL | Approved before 1982 | 5c6f7cd8ea54… | ||
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | N018297-002 | LOPURIN | 300MG | TABLET / ORAL | Approved before 1982 | 5c6f7cd8ea54… | ||
| 2022-04-08 23:34 UTC | 2022-04 | N018297-001 | LOPURIN | 100MG | TABLET / ORAL | Approved before 1982 | 5d02ea3f76ae… | ||
| 2022-04-08 23:34 UTC | 2022-04 | N018297-002 | LOPURIN | 300MG | TABLET / ORAL | Approved before 1982 | 5d02ea3f76ae… | ||
| 2022-04-04 05:41 UTC | 2022-04 | N018297-001 | LOPURIN | 100MG | TABLET / ORAL | Approved before 1982 | 4b0b4de00fa7… | ||
| 2022-04-04 05:41 UTC | 2022-04 | N018297-002 | LOPURIN | 300MG | TABLET / ORAL | Approved before 1982 | 4b0b4de00fa7… | ||
| 2019-12-13 00:20 UTC | 2019-12 | N018297-001 | LOPURIN | 100MG | TABLET / ORAL | Approved before 1982 | 74a2ff9319b5… | ||
| 2019-12-13 00:20 UTC | 2019-12 | N018297-002 | LOPURIN | 300MG | TABLET / ORAL | Approved before 1982 | 74a2ff9319b5… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Allopurinol | ALLOPURINOL | Bryant Ranch Prepack | f91c2183-e41d-45bc-87aa-edfca5eebac5 | 2024-07-08 | Boxed warning, Warnings, Adverse reactions | ALLOPURINOL |
| Allopurinol | ALLOPURINOL | Bryant Ranch Prepack | 005048dd-844f-468c-bf56-1a09727e3477 | 2024-07-08 | Boxed warning, Warnings, Adverse reactions | ALLOPURINOL |
| Allopurinol | ALLOPURINOL | NuCare Pharmaceuticals,Inc. | 1b1c5cde-b2ed-ebc8-e063-6394a90a66c6 | 2024-06-17 | Warnings, Adverse reactions | ALLOPURINOL |
| Allopurinol | ALLOPURINOL | Bryant Ranch Prepack | 7003e410-b4ff-da07-5571-07e7e13f67e0 | 2024-05-22 | Warnings, Adverse reactions | ALLOPURINOL |
| Allopurinol | ALLOPURINOL | Advanced Rx Pharmacy of Tennessee, LLC | 15d758f9-2ec5-ecf5-e063-6394a90a7a2c | 2024-04-11 | Warnings, Adverse reactions | ALLOPURINOL |
| Allopurinol | ALLOPURINOL | A-S Medication Solutions | 3db4e043-71ff-496a-8087-3fde0e352abf | 2024-04-11 | Warnings, Adverse reactions | ALLOPURINOL |
| Allopurinol | ALLOPURINOL | A-S Medication Solutions | 71accbc4-8bd7-4d22-ae53-c7b044a15ffa | 2024-04-11 | Warnings, Adverse reactions | ALLOPURINOL |
| Allopurinol | ALLOPURINOL | A-S Medication Solutions | 2caa5246-9422-4826-b926-a2566506d3eb | 2024-04-11 | Warnings, Adverse reactions | ALLOPURINOL |
| Allopurinol | ALLOPURINOL | A-S Medication Solutions | 7bf1be4e-72ba-407c-90b3-b70b09a25d6e | 2024-04-10 | Warnings, Adverse reactions | ALLOPURINOL |
| Allopurinol | ALLOPURINOL | A-S Medication Solutions | 11f1fc6e-b274-4132-9edd-522a819a479b | 2024-04-10 | Warnings, Adverse reactions | ALLOPURINOL |
| Allopurinol | ALLOPURINOL | A-S Medication Solutions | 420d338d-4d0d-4e38-bfe2-a83256821b45 | 2024-04-10 | Warnings, Adverse reactions | ALLOPURINOL |
| Allopurinol | ALLOPURINOL | Bryant Ranch Prepack | 90912dd4-5abf-4fd3-8fc1-3afd057b743f | 2024-04-08 | Boxed warning, Warnings, Adverse reactions | ALLOPURINOL |
| Allopurinol | ALLOPURINOL | Bryant Ranch Prepack | e84cd8df-79d8-449f-ace2-5a4de1cdaf51 | 2024-04-08 | Boxed warning, Warnings, Adverse reactions | ALLOPURINOL |
| Allopurinol | ALLOPURINOL | Actavis Pharma, Inc. | a80fe56f-8d03-423f-8e2a-7ec8c9e5045b | 2024-04-01 | Warnings, Adverse reactions | ALLOPURINOL |
| Allopurinol | ALLOPURINOL | Par Health USA, LLC | fbac3b4f-dc23-4359-ac3f-2b3fdde41af2 | 2024-01-30 | Warnings, Adverse reactions | ALLOPURINOL |
| Allopurinol | ALLOPURINOL | Proficient Rx LP | 0ca4baed-c5d8-4de4-ac17-6e5d1df15c03 | 2023-02-01 | Warnings, Adverse reactions | ALLOPURINOL |
| Allopurinol | ALLOPURINOL | Fresenius Kabi USA, LLC | 2caf5eed-2408-4ce0-bd0d-04f4c90e434d | 2023-01-24 | Warnings, Adverse reactions | ALLOPURINOL |
| Allopurinol | ALLOPURINOL | Aphena Pharma Solutions - Tennessee, LLC | 9b0e3f11-c02a-443d-806f-134c907ea371 | 2022-12-21 | Warnings, Adverse reactions | ALLOPURINOL |
| Allopurinol | ALLOPURINOL | Aphena Pharma Solutions - Tennessee, LLC | a5c35283-09d2-4bb4-bdd1-055035fa272b | 2022-12-13 | Warnings, Adverse reactions | ALLOPURINOL |
| Allopurinol | ALLOPURINOL | Aphena Pharma Solutions - Tennessee, LLC | 0155151c-6e84-4f9b-9233-60ffa7483293 | 2022-11-28 | Warnings, Adverse reactions | ALLOPURINOL |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.